Dapagliflozin (5mg), Vildagliptin SR (50mg) , .N . . . .

Dapagliflozin (5mg), Vildagliptin SR (50mg)

DAPA VILDA 50/5

1. Introduction to DAPA VILDA 50/5

DAPA VILDA 50/5 is a combination medication containing Dapagliflozin (5 mg) and Vildagliptin (50 mg). It is used primarily to manage type 2 diabetes by regulating blood sugar levels when diet and exercise alone are not sufficient. The combination therapy works on two key mechanisms: Dapagliflozin, an SGLT2 inhibitor, and Vildagliptin, a DPP-4 inhibitor. These drugs together enhance glycemic control by increasing glucose excretion through the urine and boosting insulin release while lowering glucagon levels.

2. What is DAPA VILDA 50/5? 

DAPA VILDA 50/5 is a potent medication designed for individuals with type 2 diabetes who cannot achieve adequate glycemic control through lifestyle interventions. Dapagliflozin works by reducing glucose reabsorption in the kidneys, effectively lowering blood sugar levels. On the other hand, Vildagliptin inhibits the enzyme DPP-4, which helps regulate blood sugar by increasing insulin secretion and reducing glucagon production. This combination makes DAPA VILDA 50/5 highly effective in maintaining stable blood glucose levels, especially in cases where metformin alone has failed to provide adequate control.

3. How DAPA VILDA 50/5 Affects the Body

The primary action of Dapagliflozin in DAPA VILDA 50/5 is to prevent the reabsorption of glucose by the kidneys, leading to increased glucose excretion via urine. This not only helps reduce blood sugar levels but also promotes weight loss and may lower blood pressure. Vildagliptin, meanwhile, enhances the incretin system, stimulating insulin release in response to meals and reducing the release of glucagon during fasting. This dual mechanism helps regulate postprandial and fasting glucose levels, offering a more balanced blood sugar control throughout the day. In addition to these benefits, DAPA VILDA 50/5 may have cardiovascular and renal protective effects, further improving patient outcomes.

4. Benefits of DAPA VILDA 50/5

DAPA VILDA 50/5 offers multiple benefits for managing type 2 diabetes:

1. Improved Glycemic Control: By targeting both fasting and post-meal blood glucose levels, this combination helps patients achieve better overall blood sugar management.
2. Weight Loss: Dapagliflozin’s mechanism of action promotes mild weight loss, which is a significant benefit for diabetic patients who struggle with weight management.
3. Lower Blood Pressure: As an added benefit, Dapagliflozin may help lower blood pressure in some patients, which is essential for reducing cardiovascular risk in diabetics.
4. Cardiovascular and Renal Protection: Studies suggest that Dapagliflozin may offer protective effects on the heart and kidneys, reducing the risk of heart failure and slowing the progression of kidney disease.
5. Low Risk of Hypoglycemia: Unlike some other diabetes medications, DAPA VILDA 50/5 has a relatively low risk of causing hypoglycemia, making it safer for long-term use.

5. Choosing the Best DAPA VILDA 50/5 

When considering DAPA VILDA 50/5 for diabetes management, it is crucial to assess a patient’s overall health profile. This combination drug is particularly beneficial for individuals who have not achieved sufficient glucose control with metformin alone and those at risk of cardiovascular or renal complications. It is ideal for patients with high blood sugar levels and mild obesity, as it can also aid in weight management. However, individuals with renal impairment or those prone to dehydration should use caution, as Dapagliflozin increases urine output. Before starting the medication, a thorough consultation with a healthcare provider is necessary to evaluate possible interactions and determine the most appropriate dosage.

6. DAPA VILDA 50/5 Uses 

DAPA VILDA 50/5 is primarily prescribed for the management of type 2 diabetes in adults. It is particularly effective when used as part of a comprehensive treatment plan that includes lifestyle modifications such as a healthy diet and regular physical activity. The drug is also used as an adjunct treatment for patients who do not respond adequately to metformin. The combination of Dapagliflozin and Vildagliptin helps improve both fasting and postprandial blood sugar levels, making it a well-rounded therapy for continuous glycemic control. Additionally, it may reduce the need for insulin in some patients, allowing for less intensive treatment regimens.

Practical Considerations and FAQs

7. Potential Risks and Considerations 

While DAPA VILDA 50/5 offers numerous benefits, it is essential to consider the potential risks. Common side effects include urinary tract infections, genital yeast infections, and increased urination, primarily due to the action of Dapagliflozin. In rare cases, the drug may lead to more severe complications such as dehydration, ketoacidosis, and acute kidney injury. Patients with a history of bladder cancer or severe renal impairment should use the medication cautiously or avoid it altogether. Regular monitoring of kidney function, blood pressure, and blood glucose levels is recommended to ensure the safe use of DAPA VILDA 50/5. Always follow your healthcare provider’s guidance when taking this medication to minimize risks.

8. FAQs about DAPA VILDA 50/5 

Q1: How should I take DAPA VILDA 50/5? A1: The medication is typically taken once daily, with or without food, preferably at the same time each day to maintain consistent blood levels. Always follow your healthcare provider's dosage instructions.

Q2: Can I use DAPA VILDA 50/5 if I have kidney disease? A2: Patients with mild to moderate renal impairment may use DAPA VILDA 50/5, but it is contraindicated in patients with severe kidney disease. Consult your doctor before starting the medication.

Q3: Are there any serious side effects I should be aware of? A3: Yes, while the medication is generally well-tolerated, serious side effects such as ketoacidosis, dehydration, and acute kidney injury can occur, particularly in individuals prone to dehydration or with pre-existing renal conditions.

Q4: Can DAPA VILDA 50/5 cause hypoglycemia? A4: The risk of hypoglycemia with DAPA VILDA 50/5 is low, especially when used as monotherapy. However, combining it with insulin or other hypoglycemic agents may increase the risk.

Q5: Is DAPA VILDA 50/5 safe during pregnancy? A5: The safety of DAPA VILDA 50/5 during pregnancy has not been established. It is generally recommended to avoid using this medication during pregnancy unless clearly necessary, as it may pose risks to the developing fetus.

9. Conclusion 

DAPA VILDA 50/5 is a valuable tool in the management of type 2 diabetes, offering improved glycemic control with additional benefits like weight loss and cardiovascular protection. Its dual-action mechanism makes it particularly effective for patients who have not achieved adequate blood sugar control through lifestyle changes and metformin alone. However, it is crucial to consider the potential side effects and consult a healthcare provider before starting the treatment. With regular monitoring and adherence to medical advice, DAPA VILDA 50/5 can significantly enhance quality of life for diabetic patients. Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, sterisonline and sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology. 

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp:  7877551268, 7849827488  

BUY NOW